Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astra industry | Arabia Saudita | Salute | Prodotti farmaceutici | 13,62 Mrd SAR | 24,6x | 0,62 | 170,20 SAR | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 6,1% Rialzo | Fai l’upgrade a Pro+ | |
Jamjoom Pharmaceuticals Factory | Arabia Saudita | Salute | Prodotti farmaceutici | 12,12 Mrd SAR | 38x | 1,1 | 169 SAR | -2,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 3% Rialzo | Fai l’upgrade a Pro+ | |
Pharmaceutical | Arabia Saudita | Salute | Prodotti farmaceutici | 3,74 Mrd SAR | -925x | -2,31 | 31,10 SAR | -3,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,7% Rialzo | Fai l’upgrade a Pro+ | |
Middle East Pharmaceutical | Arabia Saudita | Salute | Prodotti farmaceutici | 2,68 Mrd SAR | 32,8x | 0,99 | 133 SAR | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -7,2% Ribasso | Fai l’upgrade a Pro+ | |
Qomel | Arabia Saudita | Salute | Prodotti farmaceutici | 381,50 Mln SAR | 15,6x | 0,16 | 110 SAR | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |